deCode and Applied Biosystems enter genotyping alliance

19 July 2001

Iceland's deCode Genetics has joined forces with Applera subsidiaryApplied Biosystems in a three-year alliance to build systems for what the firms describe as "the next generation of genotyping studies," that look into the relationships between traits and genetic differences among individuals to provide insights into the genetic basis of disease.

The companies say they intend to adapt deCode's genotyping software suite and integrate it with Applied Biosystem's laboratory management software to provide "a full range of customizable solutions for the generation, management and analysis of genotyping data." Financial terms were not disclosed.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight